期刊文献+

不稳定心绞痛患者不同冠状动脉病变PCI术后炎症因子的变化及意义 被引量:1

Changes of inflammatory factors after PCI in unstable angina patients with different types of coronary lesions
下载PDF
导出
摘要 目的 探讨不稳定心绞痛患者不同类型冠状动脉病变经皮冠状动脉介入治疗(PCI)后炎症因子的变化及临床意义.方法 选取经冠状动脉造影证实的118例不稳定心绞痛患者,根据检查结果分为钙化斑块组(47例)、不稳定斑块组(37例)及稳定斑块组(34例).所有患者于手术当天及术后24h清晨采集空腹血2ml进行血清超敏C反应蛋白(hs-CRP)、TNF-α及血小板源生长因子(PDGF)水平的测定.结果 3组患者术前血清hs-CRP、TNF-α及PDGF水平的差异均无统计学意义(均P>0.05),而术后血清hs-CRP、TNF-α及PDGF水平均较术前显著增加(均P〈0.01);而且术后钙化斑块组及不稳定斑块组患者血清hs-CRP水平较稳定斑块组显著增加(P〈0.01).结论 不稳定心绞痛患者PCI术后hs-CRP、TNF-α及PDGF水平均较术前明显升高,而不稳定斑块及钙化斑块患者术后升高更为显著.因此对于不稳定斑块及钙化斑块患者术后应加强干预治疗,预防术后的炎症反应,防止支架内血栓形成. Objective To investigate the changes of inflammatory factors and its clinical significance in unstable angina patients with different type of coronary artery lesion after percutaneous coronary intervention (PCI). Methods One hundred and eighteen patients with unstable angina were enrolled in the study, including patients with stable plaque (n=34), vulnerable plaque (n=37) and calcified plaque (n=47). Serum levels of hs-CRP, TNF- α and PDGF were measured before and after PCI. Results There were no significant differences in serum hs-CRP,TNF-α and PDGF levels among three groups before PCI; however, serum hs-CRP,TNF-α and PDGF levels were significantly increased after PCI. And hs-CRP was markedly increased in patients with vulnerable and calcium plaque. Conclusion Results suggest that for patients with vulnerable and calcium plaque intensive inventions should be taken to prevent inflammation and thrombosis after PCI.
出处 《浙江医学》 CAS 2010年第6期852-853,939,共3页 Zhejiang Medical Journal
关键词 超敏C反应蛋白 肿瘤坏死因子 血小板源生长因子 经皮冠状动脉介入治疗 High-sensitivity C-reactive protein Tumor necrosis factor-co Platelet derived growth factor Percutaneous coronary intervention
  • 相关文献

参考文献8

  • 1Angioi M,Abdelmouttaleb I,Rodriguez R M,et al.Increased C-reactive protein levels in patients with in-stent restenosis and its complications[J].Am J Cardiol,2001,87(10):1189-1193.
  • 2Ross R.Atherosclerosis an inflammatory disease[J].N Ensl J Med,1999,340(2):115-126.
  • 3Ridker P M,Hennekens C H,Buring J E,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J].N Engl J Med,2000,342(12):836-843.
  • 4段留法.血管内皮功能不全与高血压[J].国外医学(内科学分册),2002,29(1):11-14. 被引量:18
  • 5杨彬,成蓓.氯沙坦对大鼠血管损伤性重塑的影响及其与细胞凋亡的关系[J].临床心血管病杂志,2004,20(1):39-41. 被引量:6
  • 6Takase H,Sugiyama M,Nakazawa A,et al.Increased endogenous endothelium in coronary circulation is assoisated wit h restenosis after coronary angioplasty[J].Can J Cardiol,2003,19:902-906.
  • 7Ridker P M.High-senmitivity creactive protein:potential adjunct for global risk assessment in the primary prevention of cardiovascular disease[J].Circulation,2001,103:1813-1818.
  • 8Manolov D E,Koenig W,Hombach V,et al.C-reactive protein and atherosclerosis:Is there a causal link[J]? Histol Histopathol,2003,18(4):1189-1193.

二级参考文献27

  • 1Freeman E J.The angⅡ induced growth of vascular smooth muscle cells involves a phospholipase D mediated signaling mechanism[J].Arch Biochem Biophys,2000,374:363-370.
  • 2Inagami T Eguchi S.AngiotensinⅡmediated vascular smooth muscle cell growth signaling[J].Braz J Med Biol Res,2000,33:619-624.
  • 3Toda N, Kitamura Y, Okamura T. [J]. Hypertension,1997,21:3-8.
  • 4Amal JF,Warin L,Michel JB. [J]. Clin Invest,1992,90:647-652.
  • 5Nakashima M, Feleton M. [J]. Hypertension, 1995,19:110-115.
  • 6Komori K, Vanhoutte PM. [J]. Blood Vessels, 1990,27: 238-245.
  • 7Radomski MW, Palmer RMJ, Moncada S. [J]. Br J Pharmacol, 1991,92: 181-187.
  • 8Flavahan NA, Vanhoutte PM. [J]. Am J Hypertens,1994,23:345-347.
  • 9Sakurai T, Yanagisawa M, Takuwa Y, et al. [J]. Nature, 1990,348:732-735.
  • 10Caldwell PRB, Seegal BC. [J]. Science, 1976, 191:1050-1051.

共引文献21

同被引文献7

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部